Aldose reductase and diabetic retinopathy

Area of Science:

• Biochemistry
• Ophthalmology
• Diabetology

Background:

• Diabetic retinopathy is a leading cause of vision loss.
• Aldose reductase is an enzyme implicated in the polyol pathway, which is upregulated in diabetes.
• Elevated aldose reductase activity may contribute to diabetic complications.

Purpose of the Study:

• To investigate serum aldose reductase activity in normal subjects and diabetic patients with and without retinopathy.
• To determine if serum aldose reductase levels correlate with the presence or severity of diabetic retinopathy.

Main Methods:

• Serum aldose reductase activity was measured spectrophotometrically.
• Three groups were studied: normal subjects (n=25), diabetic patients without retinopathy (n=25), and diabetic patients with retinopathy (n=25).

Main Results:

• Serum aldose reductase levels were significantly higher in diabetic patients (with or without retinopathy) compared to normal subjects.
• Diabetic patients with retinopathy exhibited higher serum aldose reductase activity than those without retinopathy (P < .01).
• No significant difference in aldose reductase activity was observed between background and proliferative retinopathy.

Conclusions:

• Elevated serum aldose reductase activity is associated with diabetes mellitus.
• Increased aldose reductase levels may be a risk factor or indicator for diabetic retinopathy development.
• Further research is warranted to explore the therapeutic potential of aldose reductase inhibitors in preventing or treating diabetic retinopathy.